Holen Sie sich die Stockscreener-App
7.52
1.48%
0.11
Handel nachbörslich:
7.52
Schlusskurs vom Vortag:
$7.41
Offen:
$7.34
24-Stunden-Volumen:
403.44K
Relative Volume:
0.77
Marktkapitalisierung:
$361.91M
Einnahmen:
$1.49B
Nettoeinkommen (Verlust:
$160.20M
KGV:
2.3553
EPS:
3.1928
Netto-Cashflow:
$46.01M
1W Leistung:
+5.03%
1M Leistung:
-1.44%
6M Leistung:
-34.32%
1J Leistung:
+16.77%
1-Tages-Spanne:
$7.34
$7.54
1-Wochen-Bereich:
$7.06
$7.54
52-Wochen-Spanne:
$5.32
$14.62
Nu Skin Enterprises Inc Stock (NUS) Company Profile
Firmenname
Nu Skin Enterprises Inc
Sektor
Telefon
801-345-1000
Adresse
75 WEST CENTER ST, PROVO, UT
Compare NUS vs PG, UL, CL, KVUE, KMB
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUS
Nu Skin Enterprises Inc
|
7.52 | 356.62M | 1.49B | 160.20M | 46.01M | 3.1928 |
PG
Procter Gamble Co
|
142.77 | 332.61B | 85.26B | 16.53B | 14.85B | 6.7488 |
UL
Unilever Plc Adr
|
56.03 | 121.10B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
84.53 | 68.31B | 20.38B | 2.26B | 3.63B | 2.6214 |
KVUE
Kenvue Inc
|
17.30 | 32.85B | 15.12B | 1.47B | 1.72B | 0.764 |
KMB
Kimberly Clark Corp
|
96.99 | 31.91B | 17.23B | 1.75B | 1.64B | 6.0654 |
Nu Skin Enterprises Inc Stock (NUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-31 | Herabstufung | Jefferies | Buy → Hold |
| 2021-02-12 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-10-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-07-02 | Hochstufung | DA Davidson | Neutral → Buy |
| 2020-07-02 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-05 | Fortgesetzt | Citigroup | Neutral |
| 2019-11-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-10-30 | Hochstufung | Stifel | Sell → Hold |
| 2019-07-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2019-07-17 | Herabstufung | Jefferies | Buy → Hold |
| 2019-06-19 | Bestätigt | BofA/Merrill | Underperform |
| 2019-05-01 | Bestätigt | BofA/Merrill | Underperform |
| 2019-05-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-12 | Bestätigt | BofA/Merrill | Underperform |
| 2019-03-25 | Herabstufung | Stifel | Hold → Sell |
| 2018-12-06 | Bestätigt | BofA/Merrill | Underperform |
| 2018-10-10 | Eingeleitet | DA Davidson | Buy |
| 2018-08-03 | Hochstufung | Stifel | Sell → Hold |
| 2018-06-14 | Eingeleitet | Jefferies | Buy |
| 2018-02-16 | Bestätigt | Stifel | Sell |
| 2018-01-23 | Bestätigt | Citigroup | Buy |
Alle ansehen
Nu Skin Enterprises Inc Aktie (NUS) Neueste Nachrichten
Nu Skin appoints Chelsea Lantz as interim CFO after Thomas's departure - MSN
NUS | NuSkin Enterprises, Inc. Executive Compensation - Quiver Quantitative
Nu Skin Enterprises, Inc. (NUS) stock price, news, quote and history - Yahoo Finance Singapore
Nu Skin Debuts AI-Powered Platform for Personalized Nutritional Wellness - directsellingnews.com
Nu Skin (NUS) outlines 2026 votes, 2025 results and CEO pay in proxy - Stock Titan
Nu Skin Enterprises | ARS: Annual Report to Security Holders - Moomoo
[ARS] NU SKIN ENTERPRISES, INC. SEC Filing - Stock Titan
Nu Skin Enterprises, Inc. (NUS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Nu Skin Enterprises Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo
Nu Skin launches Prysm iO wellness device in U.S. for $375 By Investing.com - Investing.com South Africa
Nu Skin launches Prysm iO wellness device in U.S. for $375 - Investing.com Australia
Nu Skin Launches Prysm iO™, AI-Powered Wellness Platform - National Today
Nu Skin launches AI-powered device for nutritional wellness tracking - StreetInsider
Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness - The Joplin Globe
Nu Skin Launches Prysm iO(TM): A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness - Stockhouse
Nu Skin Enterprises Inc (NUS.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Tudor Investment Corp ET AL Sells 239,599 Shares of Nu Skin Enterprises, Inc. $NUS - marketbeat.com
Stock List: Research Stocks from Around the World - gurufocus.com
JPMorgan Chase & Co. Lowers Holdings in Nu Skin Enterprises, Inc. $NUS - marketbeat.com
Q4 2025 NU Skin Enterprises Inc Earnings Call Transcript - GuruFocus
NUS SEC FilingsNu Skin Enter 10-K, 10-Q, 8-K Forms - Stock Titan
NUS Stock Price, Quote & Chart | NU SKIN ENTERPRISES INCA (NYSE:NUS) - ChartMill
Nu Skin Enterprises | 3: Initial statement of beneficial ownership of securities- Lantz Chelsea K - Moomoo
Nu Skin (NUS) CFO Chelsea Lantz discloses 42,100-share Class A stake - stocktitan.net
Packsize Announces James D. Thomas as New Chief Financial Officer - PR Newswire
Market Trends: Is Nu Skin Enterprises Inc a top pick in the sector2026 Technicals & Target Return Focused Stock Picks - baoquankhu1.vn
Nu Skin Enterprises Restatement Agreement: Key Terms, Parties, and Signatures for 2026 Credit Facility - Minichart
Nu Skin Secures New Five-Year Credit Facilities Agreement - TipRanks
Nu Skin Enterprises | SCHEDULE 13G/A: Others - Moomoo
Nu Skin (NYSE: NUS) adds $175M term loan and $75M revolver - Stock Titan
Vanguard disaggregates holdings; reports 0 shares of Nu Skin (NYSE: NUS) - Stock Titan
Nu Skin Enterprises Inc. officially signed its Second Amended and Restated Credit Agreement on March 27, 2026, as disclosed in documents filed with the U.S. Securities and Exchange Commission. - Bitget
Chelsea Lantz - directsellingnews.com
Chelsea Lantz To Serve as Nu Skin’s Interim Chief Financial Officer - Happi | Household And Personal Products Industry
Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer - marketscreener.com
Nu Skin stock sinks after weak quarter, soft outlook - MSN
Nu Skin Enterprises Appoints Chelsea Lantz as Interim CFO Following James Thomas’ Departure - Minichart
Nu Skin names Chelsea Lantz interim CFO after Thomas departure By Investing.com - Investing.com Australia
Nu Skin (NUS) Appoints Chelsea Lantz as Interim CFO Amid Leaders - GuruFocus
NUS PE Ratio & Valuation, Is NUS Overvalued - Intellectia AI
Finanzdaten der Nu Skin Enterprises Inc-Aktie (NUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):